Metcela Company
%20.jpg)
Metcela provides regenerative medicine for treatment of Ischemic Heart Disease.
Founded Date:
2016-03-09
Last Funding Type:
Series B
Headquarters:
Japan
Investors Number:
10
Technology:
Regenerative Medicine
Employee Number:
11-50
Industry:
Biotechnology, Health Care, Medical
Estimated Revenue:
$1M to $10M
Last Funding Date:
43971
Funding Status:
Early Stage Venture
Investor Type:
For Profit
Total Funding:
950000000